Literature DB >> 28584958

A predictive diagnostic model using multiparametric MRI for differentiating uterine carcinosarcoma from carcinoma of the uterine corpus.

Yuki Kamishima1, Mitsuru Takeuchi2, Tatsuya Kawai1, Takatsune Kawaguchi3, Ken Yamaguchi4, Naoki Takahashi5, Masato Ito6, Toshinao Arakawa7, Akiko Yamamoto8, Kazushi Suzuki1, Masaki Ogawa1, Moe Takeuchi9, Yuta Shibamoto1.   

Abstract

PURPOSE: To construct a diagnostic model for differentiating carcinosarcoma from carcinoma of the uterus.
MATERIALS AND METHODS: Twenty-six patients with carcinosarcomas and 26 with uterine corpus carcinomas constituted a derivation cohort. The following nine MRI features of the tumors were evaluated: inhomogeneity, predominant signal intensity, presence of hyper- and hypointense areas, conspicuity of tumor margin, cervical canal extension on T2WI, presence of hyperintense areas on T1WI, contrast defect area volume percentage, and degree of enhancement. Two predictive models-with and without contrast-were constructed using multivariate logistic regression analysis. Fifteen other patients with carcinosarcomas and 30 patients with carcinomas constituted a validation cohort. The sensitivity and specificity of each model for the validation cohort were calculated.
RESULTS: Inhomogeneity, predominant signal intensity on T2WI, and presence of hyperintense areas on T1WI were significant predictors in the unenhanced-MRI-based model. Presence of hyperintensity on T1WI, contrast defect area volume percentage, and degree of enhancement were significant predictors in the enhanced-MRI-based model. The sensitivity/specificity of unenhanced MRI were 87/73 and 87/70% according to reviewer 1 and 2, respectively. The sensitivity/specificity of the enhanced-MRI-based model were 87/70% according to both reviewers.
CONCLUSIONS: Our diagnostic models can differentiate carcinosarcoma from carcinoma of the uterus with high sensitivity and moderate specificity.

Entities:  

Keywords:  Carcinoma; Carcinosarcoma; Endometrial neoplasms; Magnetic resonance imaging; Uterus

Mesh:

Substances:

Year:  2017        PMID: 28584958     DOI: 10.1007/s11604-017-0655-6

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  21 in total

1.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

Review 2.  Pathology of mixed Müllerian tumours.

Authors:  Emanuela D'Angelo; Jaime Prat
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-07-13       Impact factor: 5.237

3.  Malignant mixed müllerian tumors of the uterus. A clinicopathologic assessment of 34 cases.

Authors:  K W Barwick; V A LiVolsi
Journal:  Am J Surg Pathol       Date:  1979-04       Impact factor: 6.394

4.  Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.

Authors:  Frederic Amant; Isabelle Cadron; Luca Fuso; Patrick Berteloot; Eric de Jonge; Gerd Jacomen; Johan Van Robaeys; Patrick Neven; Philippe Moerman; Ignace Vergote
Journal:  Gynecol Oncol       Date:  2005-08       Impact factor: 5.482

5.  MRI appearances of uterine malignant mixed müllerian tumors.

Authors:  Nishat Bharwani; Anwen Newland; Nina Tunariu; Syed Babar; Anju Sahdev; Andrea G Rockall; Rodney H Reznek
Journal:  AJR Am J Roentgenol       Date:  2010-11       Impact factor: 3.959

6.  Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.

Authors:  Howard D Homesley; Virginia Filiaci; Maurie Markman; Pincas Bitterman; Lynne Eaton; Larry C Kilgore; Bradley J Monk; Frederick R Ueland
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

7.  Primary malignant mixed mullerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI.

Authors:  Sze Yiun Teo; Kemi T Babagbemi; Hope E Peters; Koenraad J Mortele
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

8.  The utility of preoperative endometrial sampling for the detection of uterine sarcomas.

Authors:  Nisha Bansal; Thomas J Herzog; William Burke; Carmel J Cohen; Jason D Wright
Journal:  Gynecol Oncol       Date:  2008-04-29       Impact factor: 5.482

9.  Carcinosarcoma of the uterus: radiologic-pathologic correlations with magnetic resonance imaging including diffusion-weighted imaging.

Authors:  Hiroki Kato; Masayuki Kanematsu; Tatsuro Furui; Atsushi Imai; Yoshinobu Hirose; Hiroshi Kondo; Satoshi Goshima; Yusuke Tsuge
Journal:  Magn Reson Imaging       Date:  2008-05-22       Impact factor: 2.546

10.  Utility of histogram analysis of apparent diffusion coefficient maps obtained using 3.0T MRI for distinguishing uterine carcinosarcoma from endometrial carcinoma.

Authors:  Masahiro Takahashi; Eito Kozawa; Megumi Tanisaka; Kousei Hasegawa; Masanori Yasuda; Fumikazu Sakai
Journal:  J Magn Reson Imaging       Date:  2015-11-25       Impact factor: 4.813

View more
  2 in total

1.  Carcinosarcoma of the ovary: MR and clinical findings compared with high-grade serous carcinoma.

Authors:  Tsukasa Saida; Kensaku Mori; Yumiko Oishi Tanaka; Masafumi Sakai; Taishi Amano; Shunsuke Kikuchi; Souta Masuoka; Miki Yoshida; Tomohiko Masumoto; Toyomi Satoh; Manabu Minami
Journal:  Jpn J Radiol       Date:  2020-11-20       Impact factor: 2.374

Review 2.  [MRI Findings and Differential Diagnosis of Benign and Malignant Tumors of the Uterine Corpus].

Authors:  Jihyun Kim; Suk Hee Heo; Sang Soo Shin; Yong Yeon Jeong
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.